Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E3LP
|
||||
Former ID |
DIB001314
|
||||
Drug Name |
SEN-196
|
||||
Synonyms |
EX-527; SEN-0014196; SIRT1 inhibitors (Huntingtons disease), Elixir/Siena; Sirtuin-1 inhibitors (oral, Huntington's disease), Elixir/Siena
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Elixir Pharmaceuticals Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C13H13ClN2O
|
||||
InChI |
InChI=1S/C13H13ClN2O/c14-7-4-5-11-10(6-7)8-2-1-3-9(13(15)17)12(8)16-11/h4-6,9,16H,1-3H2,(H2,15,17)
|
||||
InChIKey |
FUZYTVDVLBBXDL-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
7580502, 8564414, 12015946, 16240238, 26759529, 38735740, 47524531, 48268974, 51138214, 57357382, 91106622, 103472591, 104064042, 106911508, 113739208, 117703564, 118266473, 124391161, 124584355, 125333921, 126600655, 126729602, 134224869, 135698424, 136343732, 136348247, 136367542, 136920325, 136946492, 142864246, 143403468, 144115966, 162037658, 162150401, 162202713, 163134614, 163620889, 163640315, 163686210, 163687326, 164045122, 164194033, 170305960, 172131328, 175608116, 181777870, 184597282, 185989927, 202562862, 208265236
|
||||
Target and Pathway | |||||
Target(s) | NAD-dependent deacetylase sirtuin-1 | Target Info | Inhibitor | [531699] | |
PANTHER Pathway | p53 pathway | ||||
Pathway Interaction Database | p73 transcription factor network | ||||
Signaling events mediated by HDAC Class III | |||||
E2F transcription factor network | |||||
HIF-2-alpha transcription factor network | |||||
Signaling events mediated by HDAC Class I | |||||
FoxO family signaling | |||||
Regulation of Androgen receptor activity | |||||
Regulation of retinoblastoma protein | |||||
References | |||||
Ref 523783 | ClinicalTrials.gov (NCT01521585) A Phase II Safety and Tolerability Study With SEN0014196. U.S. National Institutes of Health. | ||||
Ref 542972 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8100). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.